The Stork Ib2C, Inc., A Rinovum Women’s Health Company, Bridging the Gap for Women With Limited Access to Fertility Services and Local Clinics

The Stork® OTC offers solution to findings revealed in a recent study showing reproductive-age women need better access to at-home fertility treatment options

PITTSBURGH--()--While fertility clinics may be difficult for some women to access, there are other more accessible options. Pittsburgh-based medical device company, Rinovum Women's Health, offers solutions for building families naturally with an at-home conception device designed to help with becoming pregnant. This innovative alternative can be especially helpful for the nearly 40 percent of reproductive-age women in the United States with limited or no local access to assisted reproductive technology clinics.

The Stork® OTC (www.storkotc.com) is an FDA-cleared over-the-counter treatment device designed to optimize the chances of at-home conception using the cervical cap insemination technique. It is a safe, easy-to-use, accessible treatment option to help women become pregnant during ovulation without a prescription and in the privacy of their own home.

According to a recent study published in the journal Fertility & Sterility, 25 million reproductive-age women in the United States have limited or no access to assisted reproductive technology (ART) clinics, which provide services that are vital to many women trying to become pregnant.

The study used data from the Centers for Disease Control and Prevention to pinpoint infertility clinics in proximity to where women live in order to evaluate and assess viable access to infertility care in the United States.

“The Stork OTC is a uniquely designed medical device that has helped many couples come closer to their goal of building a family. It’s an easy-to-use, drug-free, cost-effective way to take control and optimize your chances to conceive without driving to distant clinics,” explained Dr. Michael J. Pelekanos, Board Certified OB/GYN based in Monroeville, Pa.

This type of treatment has been used effectively in the professional setting, but now it’s readily available to couples at home.

The Stork OTC can be used for common fertility issues in both men and women including:

  • Couples with unexplained infertility
  • Men with low sperm count or low sperm motility
  • Women with unfavorable vaginal environment (pH imbalances)
  • Couples trying to become pregnant without having intercourse

The Stork OTC is available for purchase at select retailers nationwide and online for the average retail price of $79.99, making it more accessible and less expensive than other first-line options for all couples trying to conceive. To learn more about how The Stork OTC works, watch the full video here. For more information and retailer and online availability, as well as pregnancy stories, visit www.storkotc.com.

About The Stork Ib2C, Inc., A Rinovum Women’s Health Company

Rinovum Women's Health is a privately held women's health company dedicated to bringing products into the market that will enhance women's lives and empower them to take charge of their health. The Stork Ib2C, Inc., A Rinovum Women’s Health Company, launched its flagship product, The Stork® OTC, which is a conception device for reproductive health to assist in natural fertility and conception in the privacy of the patient’s home. Rinovum Women's Health aims to support the development of products that are easy-to-use and safe, as well as a more economical way for a couple to address some of these issues. For more information about Rinovum Women's Health, The Stork Ib2C, Inc., and The Stork OTC, visit www.rinovum.com and www.storkotc.com.

Contacts

The Stork Ib2C, Inc., A Rinovum Women’s Health Company
Brianna Clements, 724-241-8936
bfreeman@rinovum.com

Release Summary

The Stork Ib2C, Inc., a Rinovum Women’s Health Company, bridging the gap for women with limited access to fertility services and local clinics

Contacts

The Stork Ib2C, Inc., A Rinovum Women’s Health Company
Brianna Clements, 724-241-8936
bfreeman@rinovum.com